Efficacy, safety and tolerability of tofacitinib in patients with an inadequate response to disease modifying anti-rheumatic drugs: a meta-analysis of randomized double-blind controlled studies.
about
Impact of tofacitinib on patient outcomes in rheumatoid arthritis - review of clinical studiesRecommendations for optimizing methotrexate treatment for patients with rheumatoid arthritis.Novel treatment options for juvenile idiopathic arthritis.Update on the 2012 Brazilian Society of Rheumatology Guidelines for the treatment of rheumatoid arthritis: position on the use of tofacitinib.Difficult-To-Treat Juvenile Idiopathic Arthritis: Current and Future Options.2016 updated Thai Rheumatism Association Recommendations for the use of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis.Chronic Pain in Inflammatory Arthritis: Mechanisms, Metrology, and Emerging Targets-A Focus on the JAK-STAT Pathway.
P2860
Q26772850-653F3B91-DD6E-49C5-8856-2F280903661FQ37745676-2DF3F4D0-6A6E-48C6-AA78-864146AA23A7Q38570721-94A9D7C2-6451-40DF-9C16-40F4BCF9AE3EQ38604390-D24DC928-588D-43B6-B650-DDEA63DE63CFQ38759376-741B9CC5-2E33-4931-95F8-EFCEAAA7AFE1Q48089791-1496D6B5-4790-40FA-9C8C-9D6F50708E66Q55027042-46A0A5F9-D997-489B-B2D6-94B42ECD4D41
P2860
Efficacy, safety and tolerability of tofacitinib in patients with an inadequate response to disease modifying anti-rheumatic drugs: a meta-analysis of randomized double-blind controlled studies.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Efficacy, safety and tolerabil ...... uble-blind controlled studies.
@ast
Efficacy, safety and tolerabil ...... uble-blind controlled studies.
@en
type
label
Efficacy, safety and tolerabil ...... uble-blind controlled studies.
@ast
Efficacy, safety and tolerabil ...... uble-blind controlled studies.
@en
prefLabel
Efficacy, safety and tolerabil ...... uble-blind controlled studies.
@ast
Efficacy, safety and tolerabil ...... uble-blind controlled studies.
@en
P2860
P356
P1476
Efficacy, safety and tolerabil ...... uble-blind controlled studies.
@en
P2093
Asres Berhan
P2860
P2888
P356
10.1186/1471-2474-14-332
P50
P577
2013-11-26T00:00:00Z
P5875
P6179
1047032873